This Solution Provider Webinar is brought to you by DIA in cooperation with

The pharmacovigilance landscape is evolving substantially with the changing regulatory environment and compliance requirements. With the increase in the number of drugs being approved by major regulatory authorities globally, and increased awareness, social media connectivity, and media scrutiny, pharmaceutical companies would be required to conduct surveillance of drug-related adverse events more efficiently than ever.

This webinar will detail how organizations can counter these challenges and become more sophisticated in their drug-related adverse event reporting by adopting state-of-the-art cognitive computing processes into their existing pharmacovigilance management systems. It will address how cognitive computing technologies can automate a multitude of tasks in pharmacovigilance, thereby significantly increasing productivity, reducing adverse event case-processing time and reducing overall expense, and improving compliance.

Continuing Education Credits are not available for this event.